Pancreatic Cancer Research

ResearcherKanazawa UniversityNo recent work listed

Takuya Komura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7537-1816; OpenAlex author ID A5022520705. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper

Papers 5

  1. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer … Co-author DOI 10.1136/jitc-2020-001367↗
  2. Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiation. Co-author DOI 10.1080/09553002.2019.1558297↗
  3. Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models. Co-author DOI 10.1111/cas.13944↗
  4. Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.13396↗
  5. Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact. Co-author DOI 10.1111/cas.12663↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuichi Kaneko · 5 shared papers, 2015–2020 · strength 0.36
  2. Yoshio Sakai · 5 shared papers, 2015–2020 · strength 0.36
  3. Alessandro Nasti · 3 shared papers, 2019–2020 · strength 0.25
  4. Akihiro Seki · 2 shared papers, 2019–2020 · strength 0.17
  5. Taro Yamashita · 2 shared papers, 2019–2020 · strength 0.17
  6. Tuyen Thuy Bich Ho · 2 shared papers, 2019–2020 · strength 0.17
  7. Masaki Miyazawa · 2 shared papers, 2017–2019 · strength 0.14
  8. Tetsuo Ohta · 2 shared papers, 2015–2017 · strength 0.11
  9. Haruo Fujinaga · 1 shared paper, 2019 · strength 0.08
  10. Takeshi Terashima · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.